Simultaneous gene silencing of Bcl-2, XIAP and Survivin re-sensitizes pancreatic cancer cells towards apoptosis

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Rückert, Felix ^a   Samm, Nicole ^a   Lehner, Anne Kathrin ^a   Saeger, Hans Detlev ^a   Grützmann, Robert ^a   Pilarsky, Christian ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; PROTEIN BCL 2; SMALL INTERFERING RNA; SURVIVIN; X LINKED INHIBITOR OF APOPTOSIS; BIRC5 PROTEIN, HUMAN; MESSENGER RNA; MICROTUBULE ASSOCIATED PROTEIN; XIAP PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVATION; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENE SILENCING; GENE TARGETING; GENETIC REGULATION; IN VITRO STUDY; INSTRUMENT VALIDATION; INTERMETHOD COMPARISON; PANCREAS CANCER; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SIMULTANEOUS GENE SILENCING; UPREGULATION; WESTERN BLOTTING; DRUG ANTAGONISM; GENETICS; HUMAN; METABOLISM; PANCREAS CARCINOMA; PANCREAS TUMOR; PATHOLOGY; TUMOR CELL CULTURE;

APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, PANCREATIC DUCTAL; CASPASES; ENZYME ACTIVATION; FLOW CYTOMETRY; GENE SILENCING; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; PANCREATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 77954668084     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-379     Document Type: Article

References (25)

1. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000, 100:57-70. 10.1016/S0092-8674(00)81683-9, 10647931.
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics, 2008. CA Cancer J Clin 2008, 58:71-96. 10.3322/CA.2007.0010, 18287387.
3. Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Kamiyama H, Jimeno A, et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 2008, 321:1801-1806. 10.1126/science.1164368, 2848990, 18772397.
4. Dawelbait G, Winter C, Zhang Y, Pilarsky C, Grutzmann R, Heinrich JC, Schroeder M. Structural templates predict novel protein interactions and targets from pancreas tumour gene expression data. Bioinformatics 2007, 23:i115-124. 10.1093/bioinformatics/btm188, 17646287.
5. Brown JM, Attardi LD. The role of apoptosis in cancer development and treatment response. Nat Rev Cancer 2005, 5:231-237. 10.1038/nrc1560, 15738985.
6. Eccles SA, Welch DR. Metastasis: recent discoveries and novel treatment strategies. Lancet 2007, 369:1742-1757. 10.1016/S0140-6736(07)60781-8, 2214903, 17512859.
7. Rupnow BA, Knox SJ. The role of radiation-induced apoptosis as a determinant of tumor responses to radiation therapy. Apoptosis 1999, 4:115-143. 10.1023/A:1009675028784, 14634289.
8. Rückert F, Pilarsky C, Saeger H, Grützmann R. Apoptotic Signaling in Pancreatic Cancer - Therapeutic Application. Current Cancer Therapy Reviews 2009, 5:122-133.
9. Lowe SW, Cepero E, Evan G. Intrinsic tumour suppression. Nature 2004, 432:307-315. 10.1038/nature03098, 15549092.
10. Vogler M, Durr K, Jovanovic M, Debatin KM, Fulda S. Regulation of TRAIL-induced apoptosis by XIAP in pancreatic carcinoma cells. Oncogene 2007, 26:248-257. 10.1038/sj.onc.1209776, 16832350.
11. Lopes RB, Gangeswaran R, McNeish IA, Wang Y, Lemoine NR. Expression of the IAP protein family is dysregulated in pancreatic cancer cells and is important for resistance to chemotherapy. Int J Cancer 2007, 120:2344-52. 10.1002/ijc.22554, 17311258.
12. Hinz S, Trauzold A, Boenicke L, Sandberg C, Beckmann S, Bayer E, Walczak H, Kalthoff H, Ungefroren H. Bcl-XL protects pancreatic adenocarcinoma cells against CD95-and TRAIL-receptor-mediated apoptosis. Oncogene 2000, 19:5477-5486. 10.1038/sj.onc.1203936, 11114725.
13. Vogler M, Durr K, Jovanovic M, Debatin KM, Fulda S. Regulation of TRAIL-induced apoptosis by XIAP in pancreatic carcinoma cells. Oncogene 2006, 26:248-57. 10.1038/sj.onc.1209776, 16832350.
14. Dai Y, Rahmani M, Corey SJ, Dent P, Grant S. A Bcr/Abl-independent, Lyn-dependent form of imatinib mesylate (STI-571) resistance is associated with altered expression of Bcl-2. J Biol Chem 2004, 279:34227-34239. 10.1074/jbc.M402290200, 15175350.
15. Chawla-Sarkar M, Bae SI, Reu FJ, Jacobs BS, Lindner DJ, Borden EC. Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L/TRAIL-induced apoptosis. Cell Death Differ 2004, 11:915-923. 10.1038/sj.cdd.4401416, 15118763.
16. Asanuma K, Tsuji N, Endoh T, Yagihashi A, Watanabe N. Survivin enhances Fas ligand expression via up-regulation of specificity protein 1-mediated gene transcription in colon cancer cells. J Immunol 2004, 172:3922-3929.
17. Shrikhande SV, Kleeff J, Kayed H, Keleg S, Reiser C, Giese T, Buchler MW, Esposito I, Friess H. Silencing of X-linked inhibitor of apoptosis (XIAP) decreases gemcitabine resistance of pancreatic cancer cells. Anticancer Res 2006, 26:3265-3273.
18. Esposito I, Kleeff J, Abiatari I, Shi X, Giese N, Bergmann F, Roth W, Friess H, Schirmacher P. Overexpression of cellular inhibitor of apoptosis protein 2 is an early event in the progression of pancreatic cancer. J Clin Pathol 2007, 60:885-895. 10.1136/jcp.2006.038257, 16775116.
19. Tsuji N, Asanuma K, Kobayashi D, Yagihashi A, Watanabe N. Introduction of a survivin gene-specific small inhibitory RNA inhibits growth of pancreatic cancer cells. Anticancer Res 2005, 25:3967-3972.
20. Sharma J, Srinivasan R, Majumdar S, Mir S, Radotra BD, Wig JD. Bcl-XL protein levels determine apoptotic index in pancreatic carcinoma. Pancreas 2005, 30:337-342. 10.1097/01.mpa.0000160282.64451.f1, 15841044.
21. Okamoto K, Ocker M, Neureiter D, Dietze O, Zopf S, Hahn EG, Herold C. bcl-2-specific siRNAs restore gemcitabine sensitivity in human pancreatic cancer cells. J Cell Mol Med 2007, 11:349-361. 10.1111/j.1582-4934.2007.00013.x, 17378914.
22. Qiao JG, Zhang YQ, Yin YC, Tan Z. Expression of Survivin in pancreatic cancer and its correlation to expression of Bcl-2. World J Gastroenterol 2004, 10:2759-2761.
23. Hamacher R, Schmid RM, Saur D, Schneider G. Apoptotic pathways in pancreatic ductal adenocarcinoma. Mol Cancer 2008, 7:64. 10.1186/1476-4598-7-64, 2515336, 18652674.
24. Trauzold A, Schmiedel S, Roder C, Tams C, Christgen M, Oestern S, Arlt A, Westphal S, Kapischke M, Ungefroren H, Kalthoff H. Multiple and synergistic deregulations of apoptosis-controlling genes in pancreatic carcinoma cells. Br J Cancer 2003, 89:1714-1721. 10.1038/sj.bjc.6601330, 2394395, 14583775.
25. Trauzold A, Schmiedel S, Oestern S, Christgen M, Westphal S, Roederm C, Kalthoff H. Concerted deregulations of multiple apoptosis-controlling genes in pancreatic carcinoma cells. Ann N Y Acad Sci 2003, 1010:510-513. 10.1196/annals.1299.094, 15033781.